
In the early 1990's, Drs. Jacques Dion and Mary Jensen at the University of Virginia began bench testing the procedure; they performed the first percutaneous vertebroplasty in the United States using Deramond's paradigm. Continued development and successes in Europe and the U.S. began to attract attention at scientific meetings and in the press. Initial publications and presentations at peer review meetings demonstrated an 60 to 90% success in providing immediate and significant pain relief. Medication requirements were substantially diminished, and physical and psycho-social well-being were restored.
Clinical studies have demonstrated increasing success rates and extremely low complication rates (<3% for osteoporotic patients). More than 500,000 patients have already benefited from this therapy with a reduction in pain levels. Vertebroplasty has become the standard of care for treatment of the pain associated with vertebral compression fractures.